Article
HER-2/neu gene codon 655 (Ile/Val) polymorphism in breast carcinoma patients.
Genetic testing and molecular biomarkers - 1 Mar 2011
Sezgin Ezgi, Sahin Feride Iffet, Yagmurdur Mahmut Can, Demirhan Beyhan
Abstract excerpt
Amplification and/or overexpression of HER-2/neu has been reported to be associated with poor prognosis in breast cancer. One single-nucleotide polymorphism at codon 655 indicates a guanine-to-adenine substitution (Ile655Val) in the transmembrane domain-coding region of the HER-2/neu gene reported to be associated with increased risk of breast cancer. However, several studies have shown that this association is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
